Bayer, Schering-Plough deal

SGP acquired exclusive rights to market, sell and distribute in the U.S. and Puerto Rico certain primary healthcare products from Bayer Healthcare, a unit of BAYG. The products include antibiotics Avelox moxifloxacin and Cipro ciprofloxacin, cardiovascular product Adalat nifedipine, and erectile dysfunction drug Levitra vardenafil. BAYG co-promotes Levitra with GlaxoSmithKline plc (LSE:GSK; GSL, London, U.K.).

In Japan, BAYG received rights to co-market SGP's cholesterol-lowering agent Zetia ezetimibe, which is under review in that country. BAYG also will help promote certain SGP oncology products in the U.S. and Europe. ...